Skip to main content

Table 4 Construct validity with Spearman’s rank-order correlations between ADCT total score and other patient-reported outcome measures in RELIEVE-AD

From: Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

 

Baseline

Month 1

Month 2

Month 3

Month 6

DLQI total score

0.543***

0.803***

0.828***

0.846***

0.812***

PGAD

0.489***

0.734***

0.762***

0.758***

0.705***

Skin pain

0.741***

0.831***

0.807***

0.793***

0.806***

WPAI-TAI

0.645***

0.677***

0.750***

0.772***

0.706***

WPAI-TWI

0.605***

0.644***

0.686***

0.721***

0.725***

  1. ***p < 0.001
  2. ADCT Atopic Dermatitis Control Tool, DLQI Dermatology Life Quality Index, PGAD Patient Global Assessment of Disease, WPAI-TAI Work Productivity and Activity Impairment - Total Activity Impairment, WPAI-TWI Work Productivity and Activity Impairment - Total Work Impairment